-
Putting in harm to cure: Drug related adverse events do not affect outcome of...
RationaleTreatment of multi-drug resistant Tuberculosis (MDR-TB) is challenging because it mostly relies on drugs with lower efficacy and greater toxicity than those used for... -
r37980778c78--abee98c6c8aef6336c592dba58cb41c2
Diagnostic categories for non-death serious reports of adverse events after human diploid cell rabies vaccine (HDCV, Imovax) vaccine in VAERS among persons vaccinated January 1,... -
SMQ codes related with hepatic disorder and renal disorder.
SMQ codes related with hepatic disorder and renal disorder. -
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk...
BackgroundLenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with lower-risk (Low/Intermediate-1) myelodysplastic syndrome... -
r37980778c78--2b8c8b384ec67e947fdebc20765fa3e4
Characteristics of 74 patients: 57 successful vs 17 unsuccessful outcome. -
r37980778c78--f216bb3b192eb696ad653ec1c5d3b602
BackgroundCabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. CAB is formulated both as an immediate-release oral... -
r37980778c78--2e8a56cd3f9a92fae739320e65282ad6
BackgroundWe performed a systematic review to assess whether we can quantify the underreporting of adverse events (AEs) in the published medical literature documenting the... -
Characteristics of the Trials Included in this Study.
Characteristics of the Trials Included in this Study. -
r37980778c78--ea87fd756143198776d7f66b4977b0f9
BackgroundPediatric Phase I cancer trials are critical for establishing the safety and dosing of anti-cancer treatments in children. Their implementation, however, must contend... -
r37980778c78--72f035a5ff4546edc9ce0a1a0fda18a5
Multivariable Conditional Logistic Regression for occurrence of a severe AE (Grade ≥3) (n = 1442) and for occurrence of a severe AE (Grade ≥3) after start of Cycle 2 (n = 1366). -
Listing of most frequently-reported AEs (>15% overall) and all AEs of special...
AE, adverse event; GI, gastrointestinal. -
Unadjusted Prognostic effect and adjusted prognostic effect of PSA on overall...
Unadjusted Prognostic effect and adjusted prognostic effect of PSA on overall survival. -
Trial characteristics: <i>A</i>. <i>Paniculata</i> versus Placebo (n = 4).
Trial characteristics: A. Paniculata versus Placebo (n = 4). -
Distribution of clients circumcised through ShangRing by county, facility, an...
Distribution of clients circumcised through ShangRing by county, facility, and age band (N = 1,051). -
Baseline characteristics of participants.
Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous... -
Comparison of clinical parameters between AE patients with and without genito...
Comparison of clinical parameters between AE patients with and without genitourinary anomalies in the unknown genitourinary anomaly status group (N = 140).
